The rapid, necessary expansion of telehealth billing flexibility during the pandemic created new opportunities for fraud that had not existed under the more restrictive pre-pandemic telehealth framework, prompting the Department of Justice and Department of Health and Human Services Office of Inspector General to pursue significant enforcement actions specifically targeting telehealth-related fraud schemes — enforcement that has directly shaped subsequent program integrity policy and, at times, created compliance friction for legitimate telehealth practices caught in broader scrutiny.
The Dominant Fraud Pattern Involved Telemarketing-Driven Schemes
The most significant telehealth fraud enforcement actions have centered on a specific pattern: telemarketing operations generating leads for Medicare beneficiaries, paired with telehealth companies conducting extremely brief, often clinically superficial virtual encounters specifically to generate orders for durable medical equipment, genetic tests, or prescriptions that were then billed to Medicare — orders often generated regardless of genuine clinical need, with the telehealth "visit" serving primarily as a billing pretext rather than genuine clinical evaluation. Multiple large-scale DOJ enforcement actions have charged telehealth executives, marketers, and complicit physicians in these schemes, often involving hundreds of millions of dollars in fraudulent billing across coordinated national takedowns.
Kickback Arrangements Were a Central Enforcement Focus
A recurring element in major telehealth fraud cases involved illegal kickback arrangements — telehealth companies paying physicians a fee per order generated regardless of clinical necessity, or durable medical equipment and testing companies paying telehealth operators for referrals — arrangements that violate federal anti-kickback statutes regardless of whether the underlying service would otherwise have been medically appropriate. These kickback schemes were frequently a more legally straightforward enforcement target than proving the clinical inappropriateness of the underlying prescriptions or orders themselves.
How This Enforcement History Has Shaped Ongoing Program Integrity Scrutiny
These enforcement actions have prompted CMS and program integrity contractors to apply heightened scrutiny to specific telehealth billing patterns associated with the identified fraud schemes — including unusually high volumes of durable medical equipment or genetic testing orders generated by a telehealth practice with limited follow-up care, and billing patterns showing minimal actual clinical documentation relative to the complexity of services ordered. Legitimate telehealth practices with genuinely high patient volumes and appropriate clinical documentation have sometimes reported increased administrative burden responding to audit requests triggered by this heightened scrutiny, even without having engaged in any actual improper conduct.
Documentation Standards Have Become a Key Compliance Focus
In response to this enforcement environment, compliance-focused telehealth practices have generally strengthened documentation practices specifically to clearly demonstrate genuine clinical evaluation supporting any order or prescription generated during a telehealth visit — detailed clinical notes reflecting an actual patient-specific history and assessment, rather than templated, minimally customized documentation that fraud enforcement actions have specifically flagged as a hallmark of the improper schemes being prosecuted.
The Enforcement Focus Has Been Fraud-Specific, Not a Broad Attack on Telehealth
It is worth noting that these major enforcement actions have consistently targeted specific, identifiable fraud schemes involving kickbacks and clinically unsupported orders, rather than reflecting broader regulatory hostility toward telehealth as a care modality generally — CMS and DOJ officials have repeatedly stated that legitimate telehealth practice, delivering genuine clinical evaluation and appropriately documented care, remains a valued and actively supported part of the healthcare delivery system, distinct from the specific schemes being prosecuted.
Conclusion
Telehealth fraud enforcement has targeted specific, identifiable schemes built around kickbacks and clinically unsupported ordering patterns rather than telehealth practice broadly, but the resulting heightened program integrity scrutiny has meaningfully raised documentation expectations for all telehealth practices. Compliance-focused practices depend on rigorous diagnostic equipment and documentation standards to demonstrate legitimate, clinically supported care.
